Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer

  title={Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer},
  author={Sandra Blasco-Benito and Marta Seijo-Vila and Miriam Caro-Villalobos and Isabel Tundidor and Clara Andradas and Elena Garc{\'i}a‐Taboada and Jeff Wade and Stewart Smith and Manuel Guzm{\'a}n and Eduardo P{\'e}rez-G{\'o}mez and Mara Gordon and Cristina S{\'a}nchez},
  journal={Biochemical Pharmacology},

Figures and Tables from this paper

The Use of Plants’ Natural Products in Breast Cancer: Have We Already Found the New Anticancer Drug?

This chapter is an overview of agents extracted from plants with outstand results in the last six years that showed action through induction of apoptosis, down regulation of inflammation, epigenetics, hormonal modulation, among other.

Cannabis with breast cancer treatment: propitious or pernicious?

The data identified an intra-entourage effect present in the MCF-7 cells when treated with a recreational, but not a medicinal, cannabis formulation, and this effect may be due to THC partially exerting its anti-proliferative effects through the estrogen receptor (ER), present in that cell line.

Antitumor Cannabinoid Chemotypes: Structural Insights

Structurally classified cannabinoid chemotypes described so far according to their targets and types of cancer may provide structural insights into the selection of specific cannabinoid scaffolds for the development of antitumor drugs for the treatment of particular types ofcancer.

Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro

It was found that pure CBD was as potent or more potent at reducing cancer cell viability as the most potent oil tested, suggesting that there is no “entourage” effect under these specific in vitro conditions.

Anti-cancer potential of cannabis terpenes in a taxol-resistant model of breast cancer

The results indicate that cannabis terpenes, alone or combined with cannabinoids and flavonoids, produced anti-cancer effects in chemotherapy-resistant breast cancer cell lines.

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer

Atypical cannabinoids, like O-1602 and abnormal cannabidiol, exert antitumorigenic effects on paclitaxel-resistant breast cancer cells, which could represent new leads for the development of additional anticancer treatments when resistance to conventional chemotherapy occurs during the treatment of breast and possibly other cancers.

Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer

Compounds from Cannabis sativa other than cannabinoids, like the flavonoid cannflavin A, can be cytotoxic to human bladder transitional carcinoma cells and that this compound can exert synergistic effects when combined with other agents is indicated.

Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis

The potential anti-cancer effects of cannabinoids, terpenes and flavonoids, present in cannabis, are explored in this literature review.

Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts

It is shown that most of high-THC extracts demonstrate anti-cancer activity, while only certain selected extracts showed anti-inflammatory activity.



A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma

Findings support that the combined administration of TMZ and cannabinoids could be therapeutically exploited for the management of GBM.

Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

Results obtained in a panel of tumor cell lines clearly indicate that, of the five natural compounds tested, cannabidiol is the most potent inhibitor of cancer cell growth, with significantly lower potency in noncancer cells.

Towards the use of cannabinoids as antitumour agents

The current understanding of cannabinoids as antitumour agents is discussed, focusing on recent insights into the molecular mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches.

Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.

Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil

The CB system may provide new targets for the development of drugs to treat colorectal cancer, and was the most potent compound examined, followed by anandamide, whereas NAGly showed equal potency and efficacy as the polyunsaturated fatty acids.

Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies.

Pre-clinical studies demon-strate that the activation of endocannabinoid CB-1 or CB-2 receptors produces physiological effects in animal models, namely the reduction of chemotherapy-induced allodynia.

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.

This review article aims to describe and critically discuss the pharmacology and potential impact on mammalian physiology of all major phytocannabinoids, and not only of the most famous one Δ(9)-tetrahydrocannabinol, and the adaptive pro-homeostatic physiological, or maladaptive pathological, roles of the ECS in mammalian cells, tissues, and organs.

Targeting the endocannabinoid system as a potential anticancer approach

This review focused on the antitumorigenic effects induced upon modulation of this extended endocannabinoid network.

Beyond Cannabis: Plants and the Endocannabinoid System.